Form D · Biotechnology
Moleculera Labs, Inc.
Oklahoma City, OK · CIK 0001537411
Offering snapshot reported Oct 18, 2013 · SEC filing
- Reported sold
- $2.96M Offering amount: $3.21M
- Investors reported
- 28 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Sep 20, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 18, 2013 | Initial | $2,958,936 | No comparison | 28 | SEC filing |
| Oct 30, 2012 | Initial | $324,000 | No comparison | 9 | SEC filing |
| Dec 16, 2011 | Initial | $100,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-204863
Source: Form D, filed Oct 18, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Madeleine Cunningham | Executive |
| Dr. Madeleine Cunningham | Executive |
| Fred Hiller | Executive |
| Craig Shimasaki, Ph D, Mba | Director, Executive |
| David Thomison | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
800 Research Parkway, Suite 384
Oklahoma City, OK, 73104
Oklahoma City, OK, 73104